Revolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It Seems
27/4 17:20
Key PointsInvestors have grown excited about Revolution Medicines due to its promising pancreatic cancer drug, daraxonrasib....